Integrated Quantitative Investments’s GSK GSK Stock Holding History

Integrated Quantitative Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Sell	38,021 -85,893	-69%	-$4.54M	0.33%	97
2026 Q1	$6.84M	Buy	123,914 +44,884	+57%	+$2.43M	1.24%	9
2025 Q4	$3.88M	Hold	79,030	–	–	0.83%	11
2025 Q3	$3.41M	Hold	79,030	–	–	0.97%	8
2025 Q2	$3.03M	Buy	+79,030	New	+$3.02M	0.89%	12

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Integrated Quantitative Investments's GSK Position: Q2 2026 in Review

Integrated Quantitative Investments reduced its GSK (GSK) stake by 69% in Q2 2026, selling an estimated $4.54M and leaving 38,021 shares worth $1.99M. The position accounts for 0.33% of the portfolio, ranked #97.

Integrated Quantitative Investments first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.84M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Integrated Quantitative Investments held 38,021 shares of GSK worth $1.99M as of Q2 2026.
Integrated Quantitative Investments sold 85,893 GSK shares in Q2 2026, an estimated $4.54M.
GSK made up 0.33% of Integrated Quantitative Investments's portfolio in Q2 2026, its #97 holding.
Integrated Quantitative Investments first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
Integrated Quantitative Investments's GSK position peaked at $6.84M in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.